
Tara L. Martinez
Examiner (ID: 12501)
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675 |
| Total Applications | 718 |
| Issued Applications | 367 |
| Pending Applications | 92 |
| Abandoned Applications | 264 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16539399
[patent_doc_number] => 20200405812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => METHODS OF DELIVERING HEPARIN BINDING EPIDERMAL GROWTH FACTOR USING STEM CELL GENERATED EXOSOMES
[patent_app_type] => utility
[patent_app_number] => 16/517201
[patent_app_country] => US
[patent_app_date] => 2019-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16517201
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/517201 | METHODS OF DELIVERING HEPARIN BINDING EPIDERMAL GROWTH FACTOR USING STEM CELL GENERATED EXOSOMES | Jul 18, 2019 | Abandoned |
Array
(
[id] => 15035693
[patent_doc_number] => 20190328851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => Stabilised Solid Compositions of Factor VII Polypeptides
[patent_app_type] => utility
[patent_app_number] => 16/507115
[patent_app_country] => US
[patent_app_date] => 2019-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16507115
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/507115 | Stabilised Solid Compositions of Factor VII Polypeptides | Jul 9, 2019 | Abandoned |
Array
(
[id] => 15086915
[patent_doc_number] => 20190338268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => Complement Factor B Analogs and Their Uses
[patent_app_type] => utility
[patent_app_number] => 16/502623
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502623
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/502623 | Complement factor B analogs and their uses | Jul 2, 2019 | Issued |
Array
(
[id] => 15993407
[patent_doc_number] => 20200172574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => INHIBITION OF CARDIAC FIBROSIS IN MYOCARDIAL INFARCTION
[patent_app_type] => utility
[patent_app_number] => 16/460645
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16460645
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/460645 | INHIBITION OF CARDIAC FIBROSIS IN MYOCARDIAL INFARCTION | Jul 1, 2019 | Abandoned |
Array
(
[id] => 15493313
[patent_doc_number] => 20200046845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/450239
[patent_app_country] => US
[patent_app_date] => 2019-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 113055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16450239
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/450239 | CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY | Jun 23, 2019 | Abandoned |
Array
(
[id] => 15086381
[patent_doc_number] => 20190338001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the Same
[patent_app_type] => utility
[patent_app_number] => 16/443093
[patent_app_country] => US
[patent_app_date] => 2019-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16443093
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/443093 | Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the Same | Jun 16, 2019 | Abandoned |
Array
(
[id] => 14993725
[patent_doc_number] => 20190315820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => A Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the Same
[patent_app_type] => utility
[patent_app_number] => 16/443089
[patent_app_country] => US
[patent_app_date] => 2019-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16443089
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/443089 | A Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the Same | Jun 16, 2019 | Abandoned |
Array
(
[id] => 14963089
[patent_doc_number] => 20190309022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => NOVEL MODULATORS OF MELANOCORTIN RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 16/431361
[patent_app_country] => US
[patent_app_date] => 2019-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16431361
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/431361 | Modulators of melanocortin receptors | Jun 3, 2019 | Issued |
Array
(
[id] => 16883795
[patent_doc_number] => 20210169990
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-06-10
[patent_title] => Compostions for Treating Dry Eye Disease
[patent_app_type] => utility
[patent_app_number] => 16/420361
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16420361
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/420361 | Compostions for Treating Dry Eye Disease | May 22, 2019 | Abandoned |
Array
(
[id] => 16883795
[patent_doc_number] => 20210169990
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-06-10
[patent_title] => Compostions for Treating Dry Eye Disease
[patent_app_type] => utility
[patent_app_number] => 16/420361
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16420361
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/420361 | Compostions for Treating Dry Eye Disease | May 22, 2019 | Abandoned |
Array
(
[id] => 14963087
[patent_doc_number] => 20190309021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => Composition Comprising a Peptide and an Inhibitor of Viral Neuraminidase
[patent_app_type] => utility
[patent_app_number] => 16/418265
[patent_app_country] => US
[patent_app_date] => 2019-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16418265
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/418265 | Composition Comprising a Peptide and an Inhibitor of Viral Neuraminidase | May 20, 2019 | Abandoned |
Array
(
[id] => 16680760
[patent_doc_number] => 10940216
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Cyclic peptides with enhanced nerve-binding selectively, nanoparticles bound with said cyclic peptides, and use of same for real-time in vivo nerve tissue imaging
[patent_app_type] => utility
[patent_app_number] => 16/414874
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 45
[patent_no_of_words] => 9031
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16414874
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/414874 | Cyclic peptides with enhanced nerve-binding selectively, nanoparticles bound with said cyclic peptides, and use of same for real-time in vivo nerve tissue imaging | May 16, 2019 | Issued |
Array
(
[id] => 17655490
[patent_doc_number] => 20220175955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => PEPTIDE DISPLAY TO ANTIGEN PRESENTING CELLS USING LIPID VEHICLE
[patent_app_type] => utility
[patent_app_number] => 17/055197
[patent_app_country] => US
[patent_app_date] => 2019-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055197
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/055197 | PEPTIDE DISPLAY TO ANTIGEN PRESENTING CELLS USING LIPID VEHICLE | May 13, 2019 | Abandoned |
Array
(
[id] => 17029965
[patent_doc_number] => 11091771
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-17
[patent_title] => PHI-4 polypeptides and methods for their use
[patent_app_type] => utility
[patent_app_number] => 16/406216
[patent_app_country] => US
[patent_app_date] => 2019-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 87826
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 421
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16406216
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/406216 | PHI-4 polypeptides and methods for their use | May 7, 2019 | Issued |
Array
(
[id] => 14864855
[patent_doc_number] => 20190282669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => PROPHYLACTIC AND NUTRACEUTICAL THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/389451
[patent_app_country] => US
[patent_app_date] => 2019-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12050
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16389451
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/389451 | Prophylactic and nutraceutical therapy | Apr 18, 2019 | Issued |
Array
(
[id] => 14896935
[patent_doc_number] => 20190292233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => ANTIMICROBIAL PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/383823
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16859
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383823
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/383823 | Antimicrobial peptides | Apr 14, 2019 | Issued |
Array
(
[id] => 14896937
[patent_doc_number] => 20190292234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => ANTIMICROBIAL PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/383865
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383865
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/383865 | ANTIMICROBIAL PEPTIDES | Apr 14, 2019 | Abandoned |
Array
(
[id] => 18716536
[patent_doc_number] => 11793858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Bactericidal peptides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/045614
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 13078
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17045614
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/045614 | Bactericidal peptides and uses thereof | Apr 14, 2019 | Issued |
Array
(
[id] => 17720418
[patent_doc_number] => 20220213138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => CYCLIC COMPOUNDS AND METHODS OF MAKING AND USING
[patent_app_type] => utility
[patent_app_number] => 17/600922
[patent_app_country] => US
[patent_app_date] => 2019-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 443
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17600922
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/600922 | CYCLIC COMPOUNDS AND METHODS OF MAKING AND USING | Apr 3, 2019 | Pending |
Array
(
[id] => 14530051
[patent_doc_number] => 20190200646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => Beverage with Collagen and Additional Additives
[patent_app_type] => utility
[patent_app_number] => 16/353179
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353179
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/353179 | Beverage with Collagen and Additional Additives | Mar 13, 2019 | Abandoned |